Elagolix ultimately lowers circulating gonadal hormone levels by inhibiting pituitary gonadotropin receptors.
Elagolix is a gonadotropin-releasing hormone(GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis. Elagolix is an orally administered,nonpeptide small molecule gonadotropin-releasing hormone(GnRH) receptor antagonist that inhibits endogenousGnRH signaling by binding competitively to GnRH receptors in the pituitary gland.
|Package details:||10g/bottle; 100g/foil bag|
Inhibits pituitary gonadotropin releasing hormone receptor and lowers circulating blood gonadotropin levels.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!